Several years ago, Virginia Commonwealth University Massey Cancer Center became the first center in the United States to test an Israeli-invented device designed to increase the space between the prostate and the rectum in prostate cancer patients undergoing radiation therapy. Now, results from the international Phase I clinical trial show that the device has the potential to significantly reduce rectal injury, a side effect caused by unwanted radiation exposure that can leave men with compromised bowel function following treatment.
Charles Edward Geyer, Jr., M.D., F.A.C.P., has been named associate director for clinical research at Virginia Commonwealth University Massey Cancer Center and a professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective June 1, 2013.
Each year, approximately one million cancer patients undergo radiation therapy and yet many have very little understanding of how it works or what to expect. Now, a pilot study conducted at Virginia Commonwealth University Massey Cancer Center suggests that educational videos shown before the patients’ initial consultation with their radiation oncologist can significantly boost their understanding of the planning and treatment process.
Each phase of survivorship has a unique set of obstacles, but one issue is important throughout: maintaining a healthy lifestyle. According to the American Cancer Society (ACS), more than half of all cancer deaths could be prevented by making healthy lifestyle choices, such as maintaining a healthy weight, eating nutritiously, staying physically active, avoiding tobacco and limiting alcohol consumption.
Hopewell military veteran Alan Daugherty survived Desert Storm and Vietnam, but little did he know that he was also battling another war: cancer. In August 2012, he was told that he had advanced stage esophageal cancer. “I was taken by surprise, I had no symptoms, no warning,” he explained.